{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T15:54:42Z","timestamp":1760889282474},"reference-count":77,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales de Cardiologie et d'Ang\u00e9iologie"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1016\/j.ancard.2016.10.008","type":"journal-article","created":{"date-parts":[[2016,11,2]],"date-time":"2016-11-02T15:16:16Z","timestamp":1478099776000},"page":"395-403","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Traitement antiagr\u00e9gant plaquettaire chez la femme\u00a0: une sp\u00e9cificit\u00e9 li\u00e9e au sexe\u00a0?"],"prefix":"10.1016","volume":"65","author":[{"given":"A.","family":"Bellemain-Appaix","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ancard.2016.10.008_bib0390","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.ijcard.2016.07.194","article-title":"Differential trends in myocardial infarction mortality over 1975\u20132010\u00a0in France according to gender: an age-period-cohort analysis","volume":"223","author":"Gabet","year":"2016","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.ancard.2016.10.008_bib0395","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1093\/eurheartj\/ehw106","volume":"37","author":"Piepoli","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ancard.2016.10.008_bib0400","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1093\/eurheartj\/ehv320","volume":"37","author":"Roffi","year":"2016","journal-title":"Eur Heart J"},{"issue":"Suppl.\u00a0P","key":"10.1016\/j.ancard.2016.10.008_bib0405","doi-asserted-by":"crossref","first-page":"P27","DOI":"10.4244\/EIJV8SPA6","article-title":"ACS and STEMI treatment: gender-related issues","volume":"8","author":"Chieffo","year":"2012","journal-title":"EuroIntervention"},{"key":"10.1016\/j.ancard.2016.10.008_bib0410","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/j.amjcard.2012.12.011","article-title":"Relation of gender to infarct size in patients with ST-segment elevation myocardial infarction undergoing primary angioplasty","volume":"111","author":"De Luca","year":"2013","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ancard.2016.10.008_bib0415","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.atherosclerosis.2013.05.024","article-title":"Gender-related differences in outcome after BMS or DES implantation in patients with ST-segment elevation myocardial infarction treated by primary angioplasty: insights from the DESERT cooperation","volume":"230","author":"De Luca","year":"2013","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ancard.2016.10.008_bib0420","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1007\/s40265-013-0135-y","article-title":"Gender differences in cardiovascular therapy: focus on antithrombotic therapy and percutaneous coronary intervention","volume":"73","author":"Gutierrez-Chico","year":"2013","journal-title":"Drugs"},{"key":"10.1016\/j.ancard.2016.10.008_bib0425","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.ahj.2010.04.017","volume":"160","author":"Diercks","year":"2010","journal-title":"Am Heart J"},{"key":"10.1016\/j.ancard.2016.10.008_bib0430","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1136\/hrt.2005.072769","article-title":"Women and coronary disease","volume":"94","author":"Andreotti","year":"2008","journal-title":"Heart"},{"key":"10.1016\/j.ancard.2016.10.008_bib0435","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1001\/jama.295.3.306","article-title":"Aspirin for the primary prevention of cardiovascular events in women and men: a sex-specific meta-analysis of randomized controlled trials","volume":"295","author":"Berger","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.ancard.2016.10.008_bib0440","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0140-6736(02)07442-1","article-title":"Platelet glycoprotein IIb\/IIIa inhibitors in acute coronary syndromes: a meta-analysis of all major randomised clinical trials","volume":"359","author":"Boersma","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.ancard.2016.10.008_bib0445","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.annepidem.2005.06.052","article-title":"Platelet counts differ by sex, ethnicity, and age in the United States","volume":"16","author":"Segal","year":"2006","journal-title":"Ann Epidemiol"},{"key":"10.1016\/j.ancard.2016.10.008_bib0450","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1055\/s-0038-1656045","article-title":"Gender differences in platelet GPIIb\u2013IIIa activation","volume":"77","author":"Faraday","year":"1997","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.ancard.2016.10.008_bib0455","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/253355a0","article-title":"Sex and age differences in human platelet aggregation","volume":"253","author":"Johnson","year":"1975","journal-title":"Nature"},{"key":"10.1016\/j.ancard.2016.10.008_bib0460","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.atherosclerosis.2014.10.095","article-title":"Sex differences of leukocyte-platelet interactions and on-treatment platelet reactivity in patients with atherosclerosis","volume":"237","author":"Gremmel","year":"2014","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ancard.2016.10.008_bib0465","doi-asserted-by":"crossref","first-page":"157","DOI":"10.7326\/0003-4819-89-2-157","article-title":"Menopause and coronary heart disease. The Framingham Study","volume":"89","author":"Gordon","year":"1978","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ancard.2016.10.008_bib0470","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0002-9378(81)90410-5","article-title":"Early menopause and the risk of myocardial infarction","volume":"139","author":"Rosenberg","year":"1981","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ancard.2016.10.008_bib0475","first-page":"1832","article-title":"17\u00a0beta-estradiol stimulates prostacyclin, but not endothelin-1, production in human vascular endothelial cells","volume":"80","author":"Mikkola","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ancard.2016.10.008_bib0480","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/S0741-5214(98)70016-3","article-title":"Estrogen improves endothelial function","volume":"27","author":"Arora","year":"1998","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.ancard.2016.10.008_bib0485","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1056\/NEJM199906103402306","article-title":"The protective effects of estrogen on the cardiovascular system","volume":"340","author":"Mendelsohn","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ancard.2016.10.008_bib0490","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1055\/s-0038-1650033","article-title":"A sex difference in the bleeding time","volume":"43","author":"Bain","year":"1980","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.ancard.2016.10.008_bib0495","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1136\/jcp.4.3.272","article-title":"The bleeding time in normal and abnormal subjects","volume":"4","author":"O\u2019Brien","year":"1951","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.ancard.2016.10.008_bib0500","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/gme.0b013e31825ebafd","article-title":"Platelet reactivity and thrombogenicity in postmenopausal women","volume":"20","author":"Singla","year":"2013","journal-title":"Menopause"},{"key":"10.1016\/j.ancard.2016.10.008_bib0505","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1160\/TH04-09-0608","article-title":"Baseline associations between postmenopausal hormone therapy and inflammatory, haemostatic, and lipid biomarkers of coronary heart disease. The Women's Health Initiative Observational Study","volume":"93","author":"Langer","year":"2005","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.ancard.2016.10.008_bib0510","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jama.288.3.321","article-title":"Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial","volume":"288","author":"Rossouw","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.ancard.2016.10.008_bib0515","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1056\/NEJMoa030808","article-title":"Estrogen plus progestin and the risk of coronary heart disease","volume":"349","author":"Manson","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ancard.2016.10.008_bib0520","doi-asserted-by":"crossref","first-page":"197","DOI":"10.2307\/4593826","article-title":"Thromboembolism, oral contraceptives, and cigarettes","volume":"85","author":"Frederiksen","year":"1970","journal-title":"Public Health Rep"},{"key":"10.1016\/j.ancard.2016.10.008_bib0525","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/0049-3848(83)90134-2","article-title":"The sex-related differences in aspirin pharmacokinetics in rabbits and man and its relationship to antiplatelet effects","volume":"29","author":"Buchanan","year":"1983","journal-title":"Thromb Res"},{"key":"10.1016\/j.ancard.2016.10.008_bib0530","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.4155\/tde.11.117","article-title":"A GENS-based approach to cardiovascular pharmacology: impact on metabolism, pharmacokinetics and pharmacodynamics","volume":"2","author":"Franconi","year":"2011","journal-title":"Ther Deliv"},{"key":"10.1016\/j.ancard.2016.10.008_bib0535","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1111\/j.1365-2125.1985.tb02695.x","article-title":"The effects of age and sex on the disposition of acetylsalicylic acid and its metabolites","volume":"19","author":"Ho","year":"1985","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.ancard.2016.10.008_bib0540","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1001\/jama.295.12.1420","article-title":"Sex differences in platelet reactivity and response to low-dose aspirin therapy","volume":"295","author":"Becker","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.ancard.2016.10.008_bib0545","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1161\/01.CIR.0000013777.21160.07","article-title":"Aspirin-resistant thromboxane biosynthesis and the risk of myocardial infarction, stroke, or cardiovascular death in patients at high risk for cardiovascular events","volume":"105","author":"Eikelboom","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.ancard.2016.10.008_bib0550","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1093\/eurheartj\/ehi397","article-title":"Female-specific aspects in the pharmacotherapy of chronic cardiovascular diseases","volume":"26","author":"Jochmann","year":"2005","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ancard.2016.10.008_bib0555","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/j.1755-5922.2009.00106.x","article-title":"Gender and responses to aspirin and clopidogrel: insights using short thrombelastography","volume":"27","author":"Hobson","year":"2009","journal-title":"Cardiovasc Ther"},{"key":"10.1016\/j.ancard.2016.10.008_bib0560","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.jacc.2004.09.067","article-title":"Variability in platelet responsiveness to clopidogrel among 544\u00a0individuals","volume":"45","author":"Serebruany","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ancard.2016.10.008_bib0565","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s10557-016-6646-5","article-title":"Gender differences in platelet reactivity in patients receiving dual antiplatelet therapy","volume":"30","author":"Verdoia","year":"2016","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1016\/j.ancard.2016.10.008_bib0570","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1517\/14656566.9.16.2893","article-title":"Prasugrel: a novel platelet ADP P2Y12\u00a0receptor antagonist. A review on its mechanism of action and clinical development","volume":"9","author":"Angiolillo","year":"2008","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.ancard.2016.10.008_bib0575","doi-asserted-by":"crossref","first-page":"2553","DOI":"10.1161\/CIRCULATIONAHA.109.851949","article-title":"Cytochrome P450\u00a0genetic polymorphisms and the response to prasugrel: relationship to pharmacokinetic, pharmacodynamic, and clinical outcomes","volume":"119","author":"Mega","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.ancard.2016.10.008_bib0580","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1007\/s10928-008-9103-7","article-title":"Population pharmacokinetics and pharmacodynamics of prasugrel and clopidogrel in aspirin-treated patients with stable coronary artery disease","volume":"35","author":"Ernest","year":"2008","journal-title":"J Pharmacokinet Pharmacodyn"},{"key":"10.1016\/j.ancard.2016.10.008_bib0585","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.ahj.2014.06.026","article-title":"Platelet reactivity during ticagrelor maintenance therapy: a patient-level data meta-analysis","volume":"168","author":"Alexopoulos","year":"2014","journal-title":"Am Heart J"},{"key":"10.1016\/j.ancard.2016.10.008_bib0590","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1161\/hc2901.093500","article-title":"Pharmacodynamics and pharmacokinetics of eptifibatide in patients with acute coronary syndromes: prospective analysis from PURSUIT","volume":"104","author":"Tardiff","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.ancard.2016.10.008_bib0595","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1172\/JCI110973","article-title":"A murine monoclonal antibody that completely blocks the binding of fibrinogen to platelets produces a thrombasthenic-like state in normal platelets and binds to glycoproteins IIb and\/or IIIa","volume":"72","author":"Coller","year":"1983","journal-title":"J Clin Investig"},{"key":"10.1016\/j.ancard.2016.10.008_bib0600","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/S0735-1097(00)00746-4","volume":"36","author":"Cho","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ancard.2016.10.008_bib0605","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/S0735-1097(02)02120-4","article-title":"Is glycoprotein IIb\/IIIa antagonism as effective in women as in men following percutaneous coronary intervention? Lessons from the ESPRIT study","volume":"40","author":"Fernandes","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ancard.2016.10.008_bib0610","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1161\/CIRCULATIONAHA.115.017300","article-title":"Efficacy and safety of cangrelor in women versus men during percutaneous coronary intervention: insights from the cangrelor versus standard therapy to achieve optimal management of platelet inhibition (CHAMPION PHOENIX) Trial","volume":"133","author":"O\u2019Donoghue","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.ancard.2016.10.008_bib0615","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1016\/S0195-668X(03)00485-8","article-title":"Predictors of major bleeding in acute coronary syndromes: the Global Registry of Acute Coronary Events (GRACE)","volume":"24","author":"Moscucci","year":"2003","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ancard.2016.10.008_bib0620","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1161\/CIRCINTERVENTIONS.109.860494","article-title":"Significantly improved vascular complications among women undergoing percutaneous coronary intervention: a report from the Northern New England Percutaneous Coronary Intervention Registry","volume":"2","author":"Ahmed","year":"2009","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.ancard.2016.10.008_bib0625","doi-asserted-by":"crossref","first-page":"2681","DOI":"10.1161\/CIRCULATIONAHA.110.002683","volume":"123","author":"Hochholzer","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.ancard.2016.10.008_bib0630","doi-asserted-by":"crossref","first-page":"2933","DOI":"10.1093\/eurheartj\/ehr422","article-title":"Bleeding complications with the P2Y12\u00a0receptor antagonists clopidogrel and ticagrelor in the PLATelet inhibition and patient Outcomes (PLATO) trial","volume":"32","author":"Becker","year":"2011","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ancard.2016.10.008_bib0635","doi-asserted-by":"crossref","first-page":"b4531","DOI":"10.1136\/bmj.b4531","article-title":"Aspirin for primary prevention of cardiovascular events in people with diabetes: meta-analysis of randomised controlled trials","volume":"339","author":"De Berardis","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.ancard.2016.10.008_bib0640","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1745-6215-8-21","volume":"8","author":"De Berardis","year":"2007","journal-title":"Trials"},{"key":"10.1016\/j.ancard.2016.10.008_bib0645","doi-asserted-by":"crossref","first-page":"105","DOI":"10.5694\/j.1326-5377.2008.tb01932.x","article-title":"Feasibility of conducting a primary prevention trial of low-dose aspirin for major adverse cardiovascular events in older people in Australia: results from the ASPirin in Reducing Events in the Elderly (ASPREE) pilot study","volume":"189","author":"Nelson","year":"2008","journal-title":"Med J Aust"},{"key":"10.1016\/j.ancard.2016.10.008_bib0650","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1056\/NEJMoa060989","article-title":"Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events","volume":"354","author":"Bhatt","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ancard.2016.10.008_bib0655","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1016\/S0140-6736(09)60503-1","article-title":"Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials","volume":"373","author":"Baigent","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.ancard.2016.10.008_bib0660","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1741-7015-5-29","article-title":"The influence of gender on the effects of aspirin in preventing myocardial infarction","volume":"5","author":"Yerman","year":"2007","journal-title":"BMC Med"},{"key":"10.1016\/j.ancard.2016.10.008_bib0665","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S0140-6736(01)05701-4","article-title":"Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study","volume":"358","author":"Mehta","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.ancard.2016.10.008_bib0670","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1056\/NEJMoa010746","article-title":"Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation","volume":"345","author":"Yusuf","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ancard.2016.10.008_bib0675","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1001\/jama.288.19.2411","article-title":"Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial","volume":"288","author":"Steinhubl","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.ancard.2016.10.008_bib0680","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1001\/jama.294.10.1224","article-title":"Effect of clopidogrel pretreatment before percutaneous coronary intervention in patients with ST-elevation myocardial infarction treated with fibrinolytics: the PCI-CLARITY study","volume":"294","author":"Sabatine","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.ancard.2016.10.008_bib0685","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1016\/S0140-6736(05)67660-X","article-title":"Addition of clopidogrel to aspirin in 45,852\u00a0patients with acute myocardial infarction: randomised placebo-controlled trial","volume":"366","author":"Chen","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.ancard.2016.10.008_bib0690","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1056\/NEJMoa0706482","article-title":"Prasugrel versus clopidogrel in patients with acute coronary syndromes","volume":"357","author":"Wiviott","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ancard.2016.10.008_bib0695","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1056\/NEJMoa0904327","article-title":"Ticagrelor versus clopidogrel in patients with acute coronary syndromes","volume":"361","author":"Wallentin","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ancard.2016.10.008_bib0700","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1056\/NEJMoa1407024","article-title":"Prehospital ticagrelor in ST-segment elevation myocardial infarction","volume":"371","author":"Montalescot","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ancard.2016.10.008_bib0705","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1001\/archinte.159.11.1248","article-title":"A metaregression analysis of the dose-response effect of aspirin on stroke","volume":"159","author":"Johnson","year":"1999","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ancard.2016.10.008_bib0710","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1056\/NEJM198908243210804","article-title":"A randomized trial comparing ticlopidine hydrochloride with aspirin for the prevention of stroke in high-risk patients","volume":"321","author":"Hass","year":"1989","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ancard.2016.10.008_bib0715","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1016\/S0140-6736(06)68734-5","article-title":"Aspirin plus dipyridamole versus aspirin alone after cerebral ischaemia of arterial origin (ESPRIT): randomised controlled trial","volume":"367","author":"Halkes","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.ancard.2016.10.008_bib0720","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1056\/NEJMoa0805002","article-title":"Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke","volume":"359","author":"Sacco","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ancard.2016.10.008_bib0725","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0140-6736(04)16721-4","article-title":"Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial","volume":"364","author":"Diener","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.ancard.2016.10.008_bib0730","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.thromres.2004.08.004","article-title":"Haemostatic changes in pregnancy","volume":"114","author":"Brenner","year":"2004","journal-title":"Thromb Res"},{"key":"10.1016\/j.ancard.2016.10.008_bib0735","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1055\/s-0030-1270339","article-title":"Platelet function in pre-eclampsia","volume":"37","author":"Kazmi","year":"2011","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.ancard.2016.10.008_bib0740","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1161\/CIRCULATIONAHA.105.576751","article-title":"Acute myocardial infarction in pregnancy: a United States population-based study","volume":"113","author":"James","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.ancard.2016.10.008_bib0745","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.jacc.2008.03.049","article-title":"Acute myocardial infarction associated with pregnancy","volume":"52","author":"Roth","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ancard.2016.10.008_bib0750","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1097\/AOG.0b013e318213d024","article-title":"Clopidogrel use throughout pregnancy in a patient with a drug-eluting coronary stent","volume":"118","author":"Myers","year":"2011","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ancard.2016.10.008_bib0755","first-page":"1197","article-title":"Platelet antiaggregants in pregnancy","volume":"62","author":"Santiago-Diaz","year":"2009","journal-title":"Rev Esp Cardiol"},{"key":"10.1016\/j.ancard.2016.10.008_bib0760","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0828-282X(10)70397-4","article-title":"Coronary artery disease and myocardial infarction in pregnancy: a review of epidemiology, diagnosis, and medical and surgical management","volume":"26","author":"Kealey","year":"2010","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.ancard.2016.10.008_bib0765","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1007\/s11239-012-0830-7","article-title":"Successful pregnancy and delivery on prasugrel treatment: considerations for the use of dual antiplatelet therapy during pregnancy in clinical practice","volume":"36","author":"Tello-Montoliu","year":"2013","journal-title":"J Thromb Thrombolysis"},{"key":"10.1016\/j.ancard.2016.10.008_bib0385","first-page":"2015","article-title":"Use of ticagrelor in human pregnancy, the first experience","author":"Verbruggen","year":"2015","journal-title":"BMJ Case Rep"}],"container-title":["Annales de Cardiologie et d'Ang\u00e9iologie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000339281630405X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000339281630405X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,27]],"date-time":"2020-09-27T02:57:09Z","timestamp":1601175429000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000339281630405X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":77,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["S000339281630405X"],"URL":"https:\/\/doi.org\/10.1016\/j.ancard.2016.10.008","relation":{},"ISSN":["0003-3928"],"issn-type":[{"type":"print","value":"0003-3928"}],"subject":[],"published":{"date-parts":[[2016,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Traitement antiagr\u00e9gant plaquettaire chez la femme\u00a0: une sp\u00e9cificit\u00e9 li\u00e9e au sexe\u00a0?","name":"articletitle","label":"Article Title"},{"value":"Annales de Cardiologie et d'Ang\u00e9iologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ancard.2016.10.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}